MARKET

TTPH

TTPH

Tetraphase
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.920
-0.130
-4.26%
After Hours: 2.910 -0.01 -0.34% 16:05 01/17 EST
OPEN
3.110
PREV CLOSE
3.050
HIGH
3.240
LOW
2.910
VOLUME
142.80K
TURNOVER
--
52 WEEK HIGH
29.00
52 WEEK LOW
1.990
MARKET CAP
7.93M
P/E (TTM)
-0.0983
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TTPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TTPH News

  • Paratek Pharmaceuticals: Setbacks And Successes
  • Seeking Alpha - Article.01/02 14:17
  • Mid-Afternoon Market Update: China Finance Online Falls After Q3 Results; Iterum Therapeutics Shares Gain
  • Benzinga.12/27/2019 19:18
  • FCEL, MBOT, PLX and TTPH among midday movers
  • Seeking Alpha - Article.12/27/2019 17:41
  • Mid-Day Market Update: Dow Up 70 Points; Pintec Technology Shares Spike Higher
  • Benzinga.12/27/2019 17:23

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About TTPH

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous (IV) and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections. The Company also develops TP-6076 for multidrug-resistant gram-negative infections. Eravacycline is a fluorocycline antibiotic. The Company is conducting a global Phase III clinical program for eravacycline called Investigating Gram-Negative Infections Treated with Eravacycline (IGNITE). TP-271 is a fully synthetic fluorocycline being developed for respiratory disease caused by bacterial biothreat pathogens in healthy volunteers.
More

Webull offers Tetraphase Pharmaceuticals Inc (TTPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.